May 09, 2023 / 12:30PM GMT
Operator
Hello all, and a warm welcome to the Xeris Biopharma Holdings' First Quarter 2023 Financial Results Call. My name is Elisa, and I'll be the operator for today. (Operator Instructions)
I now have the pleasure of handing over to your host today, Allison Wey, Senior Vice President of Investor Relations and Corporate Communications to begin. Allison, please go ahead when you're ready.
Allison Wey - Xeris Biopharma Holdings, Inc. - SVP of IR & Corporate Communications
Thank you, Elisa. Good morning, and welcome to Xeris Biopharma's first quarter financial results conference call and webcast. A press release with the company's financial results was issued earlier this morning can be found on our website. We are joined this morning by Paul Edick, Chairman and CEO; and Steve Pieper, CFO. Paul will provide opening remarks. Steve will provide details on our financial results, then we will open the call for Q&A.
Before we begin, I would like to remind you that this call will contain forward-looking statements, which may include, but are not
Q1 2023 Xeris Biopharma Holdings Inc Earnings Call Transcript
May 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers